Concepedia
Statistics
Publications
5
Citations
855
H-Index
Active since
2005
Affiliations
Texas Liver Institute(Current)
The University of Texas at San Antonio Health Science Center
Liver Institute Northwest
Gilead Sciences (United States)
Fernando E. Membreno is an author at Texas Liver Institute specializing in pharmacotherapy, liver disease, and cirrhosis.
Publications per year
2005–2023
Sofosbuvir and ledipasvir fixed-dose combination with and without ribavirin in treatment-naive and previously treated patients with genotype 1 hepatitis C virus infection (LONESTAR): an open-label, randomised, phase 2 trial
Eric Lawitz, Fred Poordad, Phillip S. Pang et al. · The Lancet · 2013 · 549 citations
Pharmacy, Infectious Diseases, Pharmacotherapy +15
Sofosbuvir with peginterferon‐ribavirin for 12 weeks in previously treated patients with hepatitis C genotype 2 or 3 and cirrhosis
Eric Lawitz, Fred Poordad, Diana M. Brainard et al. · Hepatology · 2014 · 125 citations · Full text
Pharmacy, Infectious Diseases, Pharmacotherapy +17
A randomized, double-blind, placebo-controlled trial of aldafermin in patients with NASH and compensated cirrhosis
Mary E. Rinella, Hsiao D. Lieu, Kris V. Kowdley et al. · Hepatology · 2023 · 82 citations · Full text
Medicine, Pharmacology, Pharmacotherapy +14
Emricasan to prevent new decompensation in patients with NASH-related decompensated cirrhosis
Catherine Frenette, Zeid Kayali, Edward Mena et al. · Journal of Hepatology · 2020 · 61 citations
Medicine, Internal Medicine, Pharmacotherapy +11
Differences in long‐term survival after transjugular intrahepatic portosystemic shunt for refractory ascites and variceal bleed
Fernando E. Membreno, ARTURO L BAEZ, REKA PANDULA et al. · Journal of Gastroenterology and Hepatology · 2005 · 38 citations
Medicine, Surgery, Hepatology +16
1–5 of 5